239 related articles for article (PubMed ID: 37982888)
1. Deciphering the molecular mechanistic paths describing the chemotherapeutic potential and epigenetic regulation of curcumin in lung cancer: a mini review.
Karati D; Mukherjee S; Roy S
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2715-2725. PubMed ID: 37982888
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Understanding of Curcumin's Therapeutic Effects in Lung Cancer.
Wan Mohd Tajuddin WNB; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817718
[TBL] [Abstract][Full Text] [Related]
3. Developments in the anticancer activity of structurally modified curcumin: An up-to-date review.
Rodrigues FC; Anil Kumar NV; Thakur G
Eur J Med Chem; 2019 Sep; 177():76-104. PubMed ID: 31129455
[TBL] [Abstract][Full Text] [Related]
4. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
Bar-Sela G; Epelbaum R; Schaffer M
Curr Med Chem; 2010; 17(3):190-7. PubMed ID: 20214562
[TBL] [Abstract][Full Text] [Related]
5. Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway.
Xu X; Zhang X; Zhang Y; Wang Z
Biomed Pharmacother; 2021 Jun; 138():111439. PubMed ID: 33684690
[TBL] [Abstract][Full Text] [Related]
6. Development of curcumin as an epigenetic agent.
Fu S; Kurzrock R
Cancer; 2010 Oct; 116(20):4670-6. PubMed ID: 20597137
[TBL] [Abstract][Full Text] [Related]
7. Curcumin therapeutic promises and bioavailability in colorectal cancer.
Shehzad A; Khan S; Shehzad O; Lee YS
Drugs Today (Barc); 2010 Jul; 46(7):523-32. PubMed ID: 20683505
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma.
Salehi M; Movahedpour A; Tayarani A; Shabaninejad Z; Pourhanifeh MH; Mortezapour E; Nickdasti A; Mottaghi R; Davoodabadi A; Khan H; Savardashtaki A; Mirzaei H
Phytother Res; 2020 Oct; 34(10):2557-2576. PubMed ID: 32307773
[TBL] [Abstract][Full Text] [Related]
9. Current Status and Perspectives Regarding the Therapeutic Potential of Targeting EGFR Pathway by Curcumin in Lung Cancer.
Shafiee M; Mohamadzade E; ShahidSales S; Khakpouri S; Maftouh M; Parizadeh SA; Hasanian SM; Avan A
Curr Pharm Des; 2017; 23(13):2002-2008. PubMed ID: 28117012
[TBL] [Abstract][Full Text] [Related]
10. Curcumin and Lung Cancer: the Role of microRNAs.
Lelli D; Pedone C; Majeed M; Sahebkar A
Curr Pharm Des; 2017; 23(23):3440-3444. PubMed ID: 28067164
[TBL] [Abstract][Full Text] [Related]
11. Curcumin nanomedicine: a road to cancer therapeutics.
Yallapu MM; Jaggi M; Chauhan SC
Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
[TBL] [Abstract][Full Text] [Related]
12. Curcumin's Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions.
Zhai K; Brockmüller A; Kubatka P; Shakibaei M; Büsselberg D
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33105719
[TBL] [Abstract][Full Text] [Related]
13. An update on Curcuma as a functional food in the control of cancer and inflammation.
Schaffer M; Schaffer PM; Bar-Sela G
Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
[TBL] [Abstract][Full Text] [Related]
14. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
Shehzad A; Wahid F; Lee YS
Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
Jurenka JS
Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
[TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway.
Wang N; Feng T; Liu X; Liu Q
Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070
[TBL] [Abstract][Full Text] [Related]
17. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations.
Tang C; Liu J; Yang C; Ma J; Chen X; Liu D; Zhou Y; Zhou W; Lin Y; Yuan X
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358986
[TBL] [Abstract][Full Text] [Related]
18. Curcumin as a MicroRNA Regulator in Cancer: A Review.
Momtazi AA; Shahabipour F; Khatibi S; Johnston TP; Pirro M; Sahebkar A
Rev Physiol Biochem Pharmacol; 2016; 171():1-38. PubMed ID: 27457236
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives.
Islam MR; Rauf A; Akash S; Trisha SI; Nasim AH; Akter M; Dhar PS; Ogaly HA; Hemeg HA; Wilairatana P; Thiruvengadam M
Biomed Pharmacother; 2024 Jan; 170():116034. PubMed ID: 38141282
[TBL] [Abstract][Full Text] [Related]
20. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.
Moon DO
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
